1. Life Sciences Trend Analysis 2013
DENMARK
Life Sciences Trend Analysis 2013

2. About Us
The following statistical information has been obtained from Biotechgate. Biotechgate is a global, comprehensive, Life Sciences database encompassing the Biotechnology, Pharmaceutical and Medical Device industries.
The Scandinavian Life Sciences Database is a part of the global Biotechgate and is brought to you in partnership with SwedenBIO, Stockholm-Uppsala Life Science and Business Region Göteborg, Copenhagen Capacity and Invest in Skane.
Biotechgate is owned and operated by Venture Valuation AG, a Zurich based company specializing in independent assessment and valuation of technology-driven companies in high growth industries, such as the Life Sciences (Biotech, Pharma, Medtech), ICT, high-tech, Nanotech, Cleantech and Renewable energy.

3. Status of the Sector Denmark 2012 Statistics 2013 Statistics 133
Total Biotech Companies
148 55
Biotech - Therapeutics 68
Biotech - R&D Services 69 10
Biotech - Other 11
96%
Percentage of SME's
93% 8%
Percentage of Publicly Owned Companies 6%
USD 115 M in 2011
Financing/Capital Raised
USD 49 M in 2012 58
Licensing Opportunities

4. Key Activities of Biotechnology Companies
Historical Data
Subsector
2013
2012
Genomics and Proteomics 5% 6%
Contract Research and Manufacturing
14%
15%
Diagnostics and Analytical Services
17%
16%
Drug Delivery
Other Services and Suppliers
18%
20%
Therapeutics
29%
24%
Other
11%
13%

5. Company Foundation Timeline

6. Company Ownership Historical Data Subsector 2013 2012
Private/ Independent
82%
78%
Public 6% 8%
Subsidiary
12%
14%

7. Sources of Company Foundations
Historical Data
Company Foundation
2013
2012
Independent foundation
51%
58%
Merger 3% 4%
Spin-off from company 5%
Spin-off from public institution / NPO 1% -
Spin-off from university 7% 6%
Subsidiary
14%
23%
Other

8. Number of Employees Historical Data No. of Employees 2013 2012 1-10
41%
54%
11-50
38%
31%
51-200
14% -
Greater than 200 7% 6%

9. Products in the Pipeline

10. Financing Rounds in Denmark & 3 Major Financing Rounds
Financing for 2012/2013 Private Biotech Companies
Major Financings in 2012/2013
Sector
USD M
Egalet Ltd.
Biotech – Therapeutics & Diagnostics 14
Nuevolution A/S
Biotech – R&D 13
Santaris Pharma A/S 12

11. Biotechnology in Selected Countries

12. About Biotechgate
Biotechgate contains over 29’000 high quality company profiles which include company descriptions, contact information, product pipeline information, financing rounds and management details. Profiles are regularly updated by the companies themselves, as well as by an experienced database team, to ensure the accuracy and relevance of the data.
To register for free or learn more about the different subscription options, please visit

13. Terms of Use
The “Denmark Life Sciences Trend Analysis” is based on data entered in the Biotechgate Database available at The statistics and graphs in this presentation are based on figures and information entered in this database and we do not guarantee any accuracy hereof.
The use of the figures and graphs provided in this report is free of charge for any presentations as long as is clearly cited as the source. For all other uses please contact us for terms and conditions. Biotechgate c/o Venture Valuation VV AG Kasernenstrasse (43)
8004 Zurich
Switzerland